Hemab
PrivateLast Round
IPO Announced
Apr 10, 2026
Total Funding Raised
$506.96M
Momentum Score
25 /100
Company Overview
Hemab Therapeutics is a biotechnology company that develops prophylactic therapeutics aimed at treating bleeding and thrombosis disorders by enhancing the body's natural clotting mechanisms to prevent life-threatening complications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemab Comps
Public and private peers based on sector, stage, and business model.
Hemab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Apr 10, 2026 | ||||
| Series C | Oct 27, 2025 | ||||
| Series C | Oct 27, 2023 | ||||
| Series B | Feb 21, 2023 | ||||
| Series A | Jul 22, 2021 | ||||
Seed | Dec 14, 2020 |
Key People
Founding team and executive leadership
Hemab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | ipo |
| Access Industries | Series B |
| Evercore ISI | ipo |
| Maj Invest Equity A/S | Series C |
| RA Capital Management | Series C, Series B, Series A |
| Avoro Ventures | Series C, Series B |
| Avoro Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
$100M raised in IPO round.
- Jan 16, 2026
Developing gene therapies as part of its biologic product portfolio.
Hemab Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hemab's valuation, stock price, and market status.
